BillionToOne, Inc.·4

Jun 17, 5:47 PM ET

ten Bosch John Roderick 4

4 · BillionToOne, Inc. · Filed Jun 17, 2026

Research Summary

AI-generated summary of this filing

Updated

BillionToOne (BLLN) SVP John ten Bosch Sells 2,832 Shares

What Happened
John Roderick ten Bosch, Senior Vice President of Laboratory Operations at BillionToOne (BLLN), sold a total of 2,832 shares in two open‑market transactions on June 15, 2026. Each sale was for 1,416 shares at $101.47 per share, yielding $143,682 per trade and about $287,364 in total. These were disposals (sales), which are often routine insider liquidity events rather than affirmative bullish purchases.

Key Details

  • Transaction date: 2026-06-15 (reported on Form 4 filed 2026-06-17)
  • Trades: Two sales of 1,416 shares each at $101.47 per share
  • Total sold: 2,832 shares for approximately $287,364
  • Footnote: Transactions were made pursuant to a Rule 10b5‑1 trading plan adopted March 6, 2026
  • Shares owned after the transaction: Not specified in the provided filing
  • Timeliness: Filing covers the period 2026-06-15 and was filed 2026-06-17 (no late‑filing indication in the provided data)

Context
A 10b5‑1 trading plan allows insiders to pre‑arrange trades to avoid trading on nonpublic information; sales under such plans are typically viewed as pre‑planned liquidity rather than a real‑time signal about company prospects. This report documents sales (not purchases or option exercises) and contains no information about changes in tenure or ownership percentage beyond the reported disposals.

Insider Transaction Report

Form 4
Period: 2026-06-15
ten Bosch John Roderick
SVP of Laboratory Operations
Transactions
  • Sale

    Class A Common Stock

    [F1]
    2026-06-15$101.47/sh1,416$143,68236,384 total
  • Sale

    Class A Common Stock

    [F1]
    2026-06-15$101.47/sh1,416$143,68234,968 total
Footnotes (1)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
Signature
/s/ Thomas P. Lynch, Attorney-in-Fact|2026-06-17

Documents

1 file
  • 4
    wk-form4_1781732836.xmlPrimary

    FORM 4